May 29, 2019
Pomerantz LLP has asked a California federal judge to approve over $2.9 million in attorney fees for leading Thoratec Corp. shareholders to an $11.9 million deal with the medical equipment company to resolve class action claims it hid risks related to its implantable heart devices.
February 04, 2019
Thoratec Corp. shareholders have asked a California federal judge to give initial approval to an $11.9 million deal with the medical equipment company that would resolve class action claims it hid risks related to its implantable heart devices.
May 09, 2018
A group of Thoratec Corp. shareholders won class certification Tuesday in a recently revived suit claiming the medical device company hid risks linked to its heart devices, as a California federal judge concluded the company made material misrepresentations that could have reasonably misled investors.
May 01, 2018
A Thoratec Corp. investor urged a California federal judge on Tuesday to certify a class of shareholders in a suit that was recently revived claiming the medical device company hid the risks linked to its heart devices, arguing for a three-year class period that goes beyond when studies initially revealed the alleged misrepresentations.
October 04, 2017
A Ninth Circuit panel on Wednesday revived a putative securities class action against Thoratec Corp., finding that a lower court erred in dismissing the suit and that the shareholders had sufficient grounds for alleging that the company misled them by hiding risks associated with one of its heart devices.